Clinical trial / 2006
Pomegranate juice lengthened prostate-specific antigen doubling time in men after prostate cancer therapy.
A phase II clinical trial evaluated daily intake of eight ounces of pomegranate juice in men with rising prostate-specific antigen following prostate cancer surgery or radiation. Treatment significantly increased average prostate-specific antigen doubling time from 15 months at baseline to 54 months posttreatment (p < 0.001). Patient serum also displayed decreased prostate cancer cell proliferation, increased apoptosis, and reduced lipid oxidation markers in laboratory assays.
- Study type
- Phase II clinical trial
- Who was studied
- Men with rising prostate-specific antigen following prostate cancer surgery or radiotherapy
- What was measured
- Prostate-specific antigen doubling time and serum-induced cancer cell proliferation
THE PAPER
Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.
Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A. Clin Cancer Res, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.